Cronos Group Reports 2025 Third Quarter Results

Executive Summary

• Cronos Group reported record‑high consolidated net revenue ($36.3 M for Q3 2025, up 6% YoY), gross profit ($18.3 M, +408%) and Adjusted EBITDA ($5.7 M, a $11.7 M improvement vs. Q3 2024).
• Net income surged to $28.3 M (up $21.0 M YoY) driven by higher sales in Israel, lower operating expenses, and the completion of the Cronos GrowCo expansion.
• The company ends the quarter with a strong balance sheet: $824 M cash & short‑term investments and zero debt, providing ample liquidity for further growth initiatives.

Key Details

• Financial Highlights (Three months ended Sep 30, 2025)
• Net revenue (ex‑GrowCo): $34.4 M (+15% QoQ) → total net revenue $36.3 M (+6% YoY).
• Cronos GrowCo contribution: $1.9 M (down 55% YoY due to prior period step‑up).
• Gross profit: $18.3 M (↑ 408% QoQ, ↑ 224% YoY).
• Adjusted Gross Profit: $18.3 M (+71% YoY).
• Net income: $28.3 M (↑ 287% QoQ, ↑ 287% YoY).

• Adjusted EBITDA: $5.7 M (improved by $11.7 M vs. Q3 2024).

• Nine‑month Highlights (Jan 1 – Sep 30, 2025)

• Net revenue: $102.1 M (+17% YoY).
• Gross profit: $46.6 M (+224% YoY).
• Adjusted EBITDA: $9.7 M (+$37.4 M YoY).

• Net loss narrowed to $(2.4) M from $(3.9) M a year earlier.

• Geographic Performance

• Israel net revenue: $11.4 M (↑ 56% YoY), driven by PEACE NATURALS® brand leadership and new premium strains.

• Canada net revenue: $23.1 M (down 4% QoQ) – flower supply constraints offset by extract growth.

• Brand Updates

• Spinach®: #2 market share in Canada (4.5%), #1 in edibles (19.7%); launched new SOURZ gummies and limited‑edition vape SKUs.

• Lord Jones®: #3 chocolate edible brand (10.7% share) and leader in hash/live‑resin pre‑rolls (17.5%).

• Cronos GrowCo Expansion

• Expansion completed; sales from the new facility began Fall 2025. Expected to boost international and Canadian supply in 2026.

• Liquidity & Capital Allocation

• Cash & short‑term investments: $824 M (down 4% YoY, reflecting CAPEX, stock repurchases, dividend to non‑controlling interests).
• CAPEX FYQ3 2025: $4.6 M (down 30% QoQ) – primarily plant/equipment and intangible asset purchases.

• Stock repurchase Q3 2025: $5.5 M; dividend to NCI: $3.9 M.

• Non‑GAAP Measures

• Adjusted Gross Profit excludes inventory step‑up from the GrowCo transaction, providing a clearer view of operating performance.

• Constant‑currency net revenue up 4% QoQ (3‑month) and 17% YoY (9‑month), confirming growth is not driven by FX effects.

• Outlook & Guidance

• Management expects the GrowCo expansion to “fuel growth internationally and within Canada in 2026.”
• No formal quantitative guidance provided; focus on leveraging strong cash position for global expansion, innovation, and brand development.

Notable Quotes

“Our third quarter results reflect continued progress towards our objectives…record levels of net revenue, gross profit and adjusted EBITDA generation…” – Mike Gorenstein, Chairman, President & CEO.

“With the completion of the Cronos GrowCo expansion we are well‑positioned for growth in 2026.” – Mike Gorenstein, Chairman, President & CEO.